126 related articles for article (PubMed ID: 37871651)
1. Contribution of FDG-PET in the diagnostic assessment of cervical lymph node metastasis in Oral Cavity Squamous Cell Carcinoma (OCSCC).
Duvernay J; Schlund M; Majoufre C
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101659. PubMed ID: 37871651
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
[TBL] [Abstract][Full Text] [Related]
3. Use of Fluoro-[18F]-Deoxy-2-D-Glucose Positron Emission Tomography/Computed Tomography to Predict Immunotherapy Treatment Response in Patients With Squamous Cell Oral Cavity Cancers.
Shah H; Wang Y; Cheng SC; Gunasti L; Chen YH; Lako A; Guenette J; Rodig S; Jo VY; Uppaluri R; Haddad R; Schoenfeld JD; Jacene HA
JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):268-276. PubMed ID: 35050348
[TBL] [Abstract][Full Text] [Related]
4. The value of preoperative 18F-FDG PET/CT for the assessing contralateral neck in head and neck cancer patients with unilateral node metastasis (N1-3).
Joo YH; Yoo IR; Cho KJ; Park JO; Nam IC; Kim CS; Kim SY; Kim MS
Clin Otolaryngol; 2014 Dec; 39(6):338-44. PubMed ID: 25102759
[TBL] [Abstract][Full Text] [Related]
5. Utility of SUV
Lim RS; Ramdave S; Beech P; Billah B; Karim MN; Smith JA; Safdar A; Sigston E
Cancer Imaging; 2016 Nov; 16(1):39. PubMed ID: 27821180
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of combined assessment of the maximum standardized uptake value of F-18 FDG PET with nodal size in the diagnosis of cervical lymph node metastasis of oral squamous cell carcinoma.
Matsubara R; Kawano S; Chikui T; Kiyosue T; Goto Y; Hirano M; Jinno T; Nagata T; Oobu K; Abe K; Nakamura S
Acad Radiol; 2012 Jun; 19(6):708-17. PubMed ID: 22484437
[TBL] [Abstract][Full Text] [Related]
7. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
8. Prediction of ultrasound guided fine needle aspiration cytology results by FDG PET-CT for lymph node metastases in head and neck squamous cell carcinoma patients.
Peltenburg B; de Keizer B; Dankbaar JW; de Boer M; Willems SM; Philippens MEP; Terhaard CHJ; de Bree R
Acta Oncol; 2018 Dec; 57(12):1687-1692. PubMed ID: 30489180
[TBL] [Abstract][Full Text] [Related]
9. Effect of time-of-flight technique on the diagnostic performance of 18F-FDG PET/CT for assessment of lymph node metastases in head and neck squamous cell carcinoma.
Li CY; Klohr S; Sadick H; Weiss C; Hoermann K; Schoenberg SO; Sadick M
J Nucl Med Technol; 2014 Sep; 42(3):181-7. PubMed ID: 24970897
[TBL] [Abstract][Full Text] [Related]
10. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
11. Maximum Standardized Uptake Value (SUV
Morand GB; Vital DG; Kudura K; Werner J; Stoeckli SJ; Huber GF; Huellner MW
Sci Rep; 2018 Aug; 8(1):11817. PubMed ID: 30087375
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/MR for lymph node staging in head and neck cancer.
Platzek I; Beuthien-Baumann B; Schneider M; Gudziol V; Kitzler HH; Maus J; Schramm G; Popp M; Laniado M; Kotzerke J; van den Hoff J
Eur J Radiol; 2014 Jul; 83(7):1163-1168. PubMed ID: 24746792
[TBL] [Abstract][Full Text] [Related]
13.
Bae MR; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):237-244. PubMed ID: 31606761
[TBL] [Abstract][Full Text] [Related]
14. The use of multiple time point dynamic positron emission tomography/computed tomography in patients with oral/head and neck cancer does not predictably identify metastatic cervical lymph nodes.
Carlson ER; Schaefferkoetter J; Townsend D; McCoy JM; Campbell PD; Long M
J Oral Maxillofac Surg; 2013 Jan; 71(1):162-77. PubMed ID: 22742956
[TBL] [Abstract][Full Text] [Related]
15. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer.
Adams S; Baum RP; Stuckensen T; Bitter K; Hör G
Eur J Nucl Med; 1998 Sep; 25(9):1255-60. PubMed ID: 9724374
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative 18F-FDG PET/CT for primary head and neck squamous cell carcinoma.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim CS; Kim MS
Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1685-91. PubMed ID: 23949547
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
18. Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma.
Bianchini C; Caracciolo M; Urso L; Ciorba A; Bonsembiante A; Migliorelli A; Corazzi V; Carandina I; Ortolan N; Cittanti C; Uccelli L; Pelucchi S; Panareo S; Bartolomei M
Acta Otorhinolaryngol Ital; 2023 Aug; 43(4):235-244. PubMed ID: 37224172
[TBL] [Abstract][Full Text] [Related]
19. Utility of ¹⁸F-FDG PET/CT in identifying penile squamous cell carcinoma metastatic lymph nodes.
Rosevear HM; Williams H; Collins M; Lightfoot AJ; Coleman T; Brown JA
Urol Oncol; 2012 Sep; 30(5):723-6. PubMed ID: 21396850
[TBL] [Abstract][Full Text] [Related]
20. Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinoma.
Mochizuki Y; Omura K; Nakamura S; Harada H; Shibuya H; Kurabayashi T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):274-82. PubMed ID: 22668784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
